Javier Gomez1, Rami Doukky1,2, Guido Germano3, Piotr Slomka3. 1. Division of Cardiology, Cook County Health and Hospitals System, Chicago, IL. 2. Division of Cardiology, Rush University Medical Center, Chicago, IL. 3. Departments of Imaging, Medicine and Biomedical Sciences, Cedars-Sinai Medical Center; Los Angeles, CA.
Abstract
PURPOSE OF REVIEW: The use of quantitative analysis in single photon emission computed tomography (SPECT) and positron emission tomography (PET) has become an integral part of current clinical practice and plays a crucial role in the detection and risk stratification of coronary artery disease. Emerging technologies, new protocols, and new quantification methods have had a significant impact on the diagnostic performance and prognostic value of nuclear cardiology imaging, while reducing the need for clinician oversight. In this review, we aim to describe recent advances in automation and quantitative analysis in nuclear cardiology. RECENT FINDINGS: Recent publications have shown that fully automatic processing is feasible, limiting human input to specific cases where aberrancies are detected by the quality control software. Furthermore, there is evidence indicating that fully quantitative analysis of myocardial perfusion imaging is feasible and can achieve at least similar diagnostic accuracy as visual interpretation by an expert clinician. In addition, the use of fully automated quantification in combination with machine learning algorithms can provide incremental diagnostic and prognostic value over the traditional method of expert visual interpretation. SUMMARY: Emerging technologies in nuclear cardiology focus on automation and the use of artificial intelligence as part of the interpretation process. This review highlights the benefits and limitations of these applications, and outlines future directions in the field.
PURPOSE OF REVIEW: The use of quantitative analysis in single photon emission computed tomography (SPECT) and positron emission tomography (PET) has become an integral part of current clinical practice and plays a crucial role in the detection and risk stratification of coronary artery disease. Emerging technologies, new protocols, and new quantification methods have had a significant impact on the diagnostic performance and prognostic value of nuclear cardiology imaging, while reducing the need for clinician oversight. In this review, we aim to describe recent advances in automation and quantitative analysis in nuclear cardiology. RECENT FINDINGS: Recent publications have shown that fully automatic processing is feasible, limiting human input to specific cases where aberrancies are detected by the quality control software. Furthermore, there is evidence indicating that fully quantitative analysis of myocardial perfusion imaging is feasible and can achieve at least similar diagnostic accuracy as visual interpretation by an expert clinician. In addition, the use of fully automated quantification in combination with machine learning algorithms can provide incremental diagnostic and prognostic value over the traditional method of expert visual interpretation. SUMMARY: Emerging technologies in nuclear cardiology focus on automation and the use of artificial intelligence as part of the interpretation process. This review highlights the benefits and limitations of these applications, and outlines future directions in the field.
Authors: Kenji Fukushima; Mehrbod S Javadi; Takahiro Higuchi; Riikka Lautamäki; Jennifer Merrill; Stephan G Nekolla; Frank M Bengel Journal: J Nucl Med Date: 2011-04-15 Impact factor: 10.057
Authors: Ji Chen; Ernest V Garcia; Jeroen J Bax; Ami E Iskandrian; Salvador Borges-Neto; Prem Soman Journal: J Nucl Cardiol Date: 2011-08 Impact factor: 5.952
Authors: Manish Motwani; William D Leslie; Andrew L Goertzen; Yuka Otaki; Guido Germano; Daniel S Berman; Piotr J Slomka Journal: J Nucl Cardiol Date: 2017-03-13 Impact factor: 5.952
Authors: Reza Arsanjani; Yuan Xu; Sean W Hayes; Mathews Fish; Mark Lemley; James Gerlach; Sharmila Dorbala; Daniel S Berman; Guido Germano; Piotr Slomka Journal: J Nucl Med Date: 2013-01-11 Impact factor: 10.057
Authors: Yuan Xu; Paul Kavanagh; Mathews Fish; James Gerlach; Amit Ramesh; Mark Lemley; Sean Hayes; Daniel S Berman; Guido Germano; Piotr J Slomka Journal: J Nucl Med Date: 2009-08-18 Impact factor: 10.057
Authors: Leslee J Shaw; Daniel S Berman; David J Maron; G B John Mancini; Sean W Hayes; Pamela M Hartigan; William S Weintraub; Robert A O'Rourke; Marcin Dada; John A Spertus; Bernard R Chaitman; John Friedman; Piotr Slomka; Gary V Heller; Guido Germano; Gilbert Gosselin; Peter Berger; William J Kostuk; Ronald G Schwartz; Merill Knudtson; Emir Veledar; Eric R Bates; Benjamin McCallister; Koon K Teo; William E Boden Journal: Circulation Date: 2008-02-11 Impact factor: 29.690
Authors: Marc Wilson; Reena Chopra; Megan Z Wilson; Charlotte Cooper; Patricia MacWilliams; Yun Liu; Ellery Wulczyn; Daniela Florea; Cían O Hughes; Alan Karthikesalingam; Hagar Khalid; Sandra Vermeirsch; Luke Nicholson; Pearse A Keane; Konstantinos Balaskas; Christopher J Kelly Journal: JAMA Ophthalmol Date: 2021-09-01 Impact factor: 7.389